Literature DB >> 27637960

Neuroepidemiology of traumatic brain injury.

A J Gardner1, R Zafonte2.   

Abstract

Traumatic brain injury (TBI) is a significant public-health concern. TBI is defined as an acute brain injury resulting from mechanical energy to the head from external physical forces. Some of the leading causes of TBI include falls, assaults, motor vehicle or traffic accidents, and sport-related concussion. Two of the most common identified risk factors are sex (males are nearly three times more likely to suffer a TBI than females); and a bimodal age pattern (persons 65 years and older, and children under 14 years old). It is estimated that approximately 1.5-2 million Americans suffer from TBI annually. TBIs account for around 1.4 million emergency room visits, 275 000 hospital admissions, and 52 000 deaths in the USA each year. TBI contributes to approximately 30% of all deaths in the USA annually. In Australia, it is estimated that approximately 338 700 individuals (1.9% of the population) suffer from a disability related to TBI. Of these, 160 200 were severely or profoundly affected by acquired brain injury, requiring daily support. In the UK, TBI accounted for 3.4% of all emergency department attendances annually. An overall rate of 453 per 100 000 was found for all TBI severities, of which 40 per 100 000 (10.9%) were moderate to severe. TBI often results in residual symptoms that affect an individual's cognition, movement, sensation, and/or emotional functioning. Recovery and rehabilitation from TBI may require considerable resources and may take years. Some individuals never fully recover, and some require lifetime ongoing care and support. TBI has an enormous social and financial cost, with estimates of the annual financial burden associated with TBI ranging between 9 and 10 billion US dollars.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  concussion; injury severity; loss of consciousness; neuroinflammation; neurometabolic cascade; postconcussion syndrome; posttraumatic amnesia; traumatic brain injury

Mesh:

Year:  2016        PMID: 27637960     DOI: 10.1016/B978-0-12-802973-2.00012-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  25 in total

1.  Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Anandakumar Shunmugavel; Tajinder S Dhammu; Hamza Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2018-07-19       Impact factor: 4.164

Review 2.  Brain metabolism and severe pediatric traumatic brain injury.

Authors:  Heidi Griffiths; Manu S Goyal; Jose A Pineda
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

3.  Six-month outcomes in patients with hemorrhagic and non-hemorrhagic traumatic disorders of consciousness.

Authors:  Sergio Bagnato; Maria Enza D'Ippolito; Cristina Boccagni; Antonio De Tanti; Lucia Francesca Lucca; Valeria Pingue; Valentina Colombo; Francesca Rubino; Maria Andriolo
Journal:  Neurol Sci       Date:  2022-08-17       Impact factor: 3.830

4.  Beyond Binary: Influence of Sex and Gender on Outcome after Traumatic Brain Injury.

Authors:  Katherine R Giordano; Luisa M Rojas-Valencia; Vedanshi Bhargava; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2020-09-02       Impact factor: 5.269

5.  Hyperthermia and Mild Traumatic Brain Injury: Effects on Inflammation and the Cerebral Vasculature.

Authors:  Jessie S Truettner; Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2018-02-09       Impact factor: 5.269

Review 6.  Racial and Ethnic Disparities Associated with Traumatic Brain Injury Across the Continuum of Care: a Narrative Review and Directions for Future Research.

Authors:  Altaf Saadi; Sarah Bannon; Eric Watson; Ana-Maria Vranceanu
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-17

7.  Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR‑145‑3p/NFATc2/NF‑κB axis.

Authors:  Can Cui; Dengwen Zhang; Ke Sun; Haifeng Li; Liqian Xu; Gen Lin; Yuanbo Guo; Jiaqi Hu; Jieyuan Chen; Lidan Nong; Yujin Cai; Dongnan Yu; Wei Yang; Peng Wang; Yi Sun
Journal:  Int J Mol Med       Date:  2021-05-26       Impact factor: 4.101

8.  Transforming Growth Factor-β3/Recombinant Human-like Collagen/Chitosan Freeze-Dried Sponge Primed With Human Periodontal Ligament Stem Cells Promotes Bone Regeneration in Calvarial Defect Rats.

Authors:  Shiyi Huang; Fenglin Yu; Yating Cheng; Yangfan Li; Yini Chen; Jianzhong Tang; Yu Bei; Qingxia Tang; Yueping Zhao; Yadong Huang; Qi Xiang
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

9.  Antithrombin III ameliorates post-traumatic brain injury cerebral leukocyte mobilization enhancing recovery of blood brain barrier integrity.

Authors:  Mohamed ElSaadani; Syed M Ahmed; Christina Jacovides; Alfonso Lopez; Victoria E Johnson; Lewis J Kaplan; C William Schwab; Douglas H Smith; Jose L Pascual
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.313

10.  Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis.

Authors:  Ashley Steed; Stuart H Friess; Marta Celorrio; Miguel A Abellanas; James Rhodes; Victoria Goodwin; Jennie Moritz; Sangeetha Vadivelu; Leran Wang; Rachel Rodgers; Sophia Xiao; Ilakkia Anabayan; Camryn Payne; Alexandra M Perry; Megan T Baldridge; Maria S Aymerich
Journal:  Acta Neuropathol Commun       Date:  2021-03-10       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.